Myomar Molecular is developing a diagnostic tool to identify early stages of muscle atrophy.
Myomar Molecular has raised $1.4M in total funding. The most recent round was Debt Financing. The last funding was announced in May 2026.
Myomar Molecular's investors include Business Development Bank of Canada, Atlantic Canada Opportunities Agency, Ontario Centres of Excellence, Northern Ontario Angels, Northern Ontario Heritage Fund.
Myomar Molecular is headquartered in Halifax, Canada.
Myomar Molecular is developing a diagnostic tool to identify early stages of muscle atrophy.
Myomar Molecular is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Myomar Molecular — Funding & Investors." VCBacked, May 11, 2026, https://www.vcbacked.co/company/myomar-molecular. Accessed July 21, 2026.
VCBacked. (2026). Myomar Molecular — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/myomar-molecular
{{cite web |title=Myomar Molecular — Funding & Investors |url=https://www.vcbacked.co/company/myomar-molecular |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated